Expression of interleukin-6 in ocular surface squamous neoplasia.
Masoomeh EghtedariVahid BeigiMehrnoosh MaalhaghHossein AshrafPublished in: Clinical ophthalmology (Auckland, N.Z.) (2019)
IL-6 expressed more in the dysplastic group in compare to non-neoplastic conjunctiva and can therefore be used to diagnose dysplastic state of the conjunctiva; however, in our study, intensity of staining does not correlate with the severity of dysplasia statistically; most probably because of a low sample size in each category. The role of nuclear staining is not clear. Our findings can be an introduction toward targeted treatment of ocular surface neoplasia by the aim of newer anti-IL agents. Further investigation is needed.